Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Volta Labs

Explore full profile

Develops scalable automation for genetic engineering

Boston, United StatesFounded 2018Biotech & Life Sciences
Valuation $100–250M Last recorded · 2024
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Volta Labs and the history behind them.

About Volta Labs

Volta Labs, Inc. is a pioneering startup based in Boston, Massachusetts, focused on revolutionizing the field of genomics. The company operates at the intersection of software development and advanced biochemistry, aiming to unlock the full potential of genomic data for a global audience. Volta Labs serves a diverse range of clients, including research institutions, clinical laboratories, and biotech companies, who require precise and efficient genomic analysis.

The market Volta Labs operates in is the rapidly growing genomics sector, which involves the study of an organism's complete set of DNA, including all of its genes. This market is crucial for advancements in personalized medicine, biotechnology, and various scientific research fields. By providing innovative solutions that streamline and enhance genomic data processing, Volta Labs positions itself as a key player in this high-demand industry.

Volta Labs' business model revolves around the development and deployment of sophisticated software tools and applications that facilitate accurate genomic analysis. The company's App Development team ensures that their technology is equipped with the necessary scripting to generate precise sample results. This software is then licensed to laboratories and research institutions, providing a steady revenue stream. Additionally, Volta Labs may engage in the sale of personal data, under strict privacy regulations, to further monetize their offerings.

Revenue generation for Volta Labs primarily comes from software licensing fees, service contracts, and potentially data monetization. By offering cutting-edge technology that enhances the efficiency and accuracy of genomic analysis, Volta Labs meets the critical needs of its clients, ensuring a competitive edge in the genomics market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Boston, United States
Employees
51
Open positions
2
Dealroom signal
77.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Techbio, Hard Tech, YC W19, DT and LS, science-based
Technology
Deep Tech
Business model
SaaS
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jan 2024 $4.3M $100M Undisclosed ↗
SERIES A✓Equity / VC Mar 2022 $20M $80M Anne Wojcicki · John Stuelpnagel · Paul McEwan · Maverick Ventures ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Volta Labs website traffic

Latest recorded traffic for Volta Labs is 7.4K monthly website visits, up 174.1% over the last three months. Volta Labs's team grew 6.3% over the past year.

Latest monthly visits7.4K 3-month web change+174.1% 1-year team growth+6.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
ExpressionEditsRedefining the status quo of protein expression with direct impact on recombinant protein yields and the quality and efficacy of DNA medicines Cambridge, United Kingdom Operational 26 $13M $52M
CellVoyantAn AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases Bristol, United Kingdom Operational
CardiaTecApplying artificial intelligence on large-scale human multiomic data to develop the next generation of cardiovascular disease targets Cambridge, United Kingdom Operational
BactobioLondon-based biotechnology company using breakthrough technologies in synthetic biology London, United Kingdom Operational
Aligned BioAligned Bio's technology makes nanowire sensors cost-effective. The use of three patented technologies allows to improve biomarker detection platform devices by 20 times Lund Municipality, Sweden Operational
1910 GeneticsA biotechnology company integrating AI, computation, and biological automation to accelerate the design of small molecule and protein therapeutics Boston, United States Operational
NanoSyrinxA cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector Coventry, United Kingdom Operational
Nucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine Oxford, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A9 investors entered at this stage

Other known investors5 additional known investors

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States88.1%
🇫🇷 France2.4%
🇸🇬 Singapore2.4%
🇳🇱 Netherlands2.4%
🇺🇬 Uganda2.4%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Volta Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Volta Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.